Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma. | Int J Mol Sci | 2021 | 34768783 | PubTator, text mining | PubMed |
| Editorial: Transcriptional Regulation as a Key Player in Cancer Cells Drug Resistance. | Front Oncol | 2021 | 34765559 | PubTator, text mining | PubMed |
| [Clinical outcomes of 31 patients with acute leukemia receiveing modified conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 34753232 | PubTator, text mining | PubMed |
| TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling. | Cell Death Dis | 2021 | 34750375 | PubTator, text mining | PubMed |
| MYC overexpression is associated with an early disease progression from MDS to AML. | Leuk Res | 2021 | 34749168 | PubTator, text mining | PubMed |
| LukS-PV Induces Apoptosis via the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells. | Front Oncol | 2021 | 34745943 | PubTator, text mining | PubMed |
| Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. | Front Endocrinol (Lausanne) | 2021 | 34745015 | PubTator, text mining | PubMed |
| Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia. | J Cell Mol Med | 2021 | 34741393 | PubTator, text mining | PubMed |
| Conservation and divergence in gene regulation between mouse and human immune cells deserves equal emphasis. | Trends Immunol | 2021 | 34740529 | PubTator, text mining | PubMed |
| Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing. | Neoplasia | 2021 | 34735995 | PubTator, text mining | PubMed |
| Gastric myeloid sarcoma: A case report. | World J Clin Oncol | 2021 | 34733617 | PubTator, text mining | PubMed |
| Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment. | Exp Hematol Oncol | 2021 | 34732266 | PubTator, text mining | PubMed |
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML. | Trials | 2021 | 34732236 | PubTator, text mining | PubMed |
| Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report. | Braz J Med Biol Res | 2021 | 34730684 | PubTator, text mining | PubMed |
| Bayesian variable selection for high-dimensional data with an ordinal response: identifying genes associated with prognostic risk group in acute myeloid leukemia. | BMC Bioinformatics | 2021 | 34727888 | PubTator, text mining | PubMed |
| Metagenomic strategies identify diverse integron-integrase and antibiotic resistance genes in the Antarctic environment. | Microbiologyopen | 2021 | 34713606 | PubTator, text mining | PubMed |
| Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies. | Genome Med | 2021 | 34711268 | PubTator, text mining | PubMed |
| Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia. | Sci Rep | 2021 | 34707164 | PubTator, text mining | PubMed |
| Identification of Endothelial Proteins in Plasma Associated With Cardiovascular Risk Factors. | Arterioscler Thromb Vasc Biol | 2021 | 34706560 | PubTator, text mining | PubMed |
| New prognostic factors and scoring system for patients with acute myeloid leukemia. | Oncol Lett | 2021 | 34691250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=50